Search results
China is pumping another $47.5 billion into its chip industry
Erie News Now Plus· 1 hour agoThe first phase of the fund was set up in 2014 with 138.7 billion yuan ($19.2 billion). The second phase was established five years later, with a registered capital of 204.1 billion yuan ($28.2 billion).
HI-Bio reports findings from Phase II trial in kidney transplant recipients
Clinical Trials Arena via Yahoo Finance· 2 hours agoHuman Immunology Biosciences (HI-Bio) has reported positive outcomes from the Phase II clinical...
In India, voters sweat their way toward the end of the election
NBC News via Yahoo News· 22 minutes agoTemperatures soared as high as 113 degrees Fahrenheit on Saturday in New Delhi as the capital and...
A key phase in Biden's new student-loan forgiveness plan has wrapped up, bringing borrowers one step...
Business Insider· 1 day agoA key phase in Biden's new student-loan forgiveness plan has wrapped up, bringing borrowers one step...
Arcona secures contract for Phase II of Zinko refurbishment project in Sweden
World Construction Network via Yahoo Finance· 3 hours agoVeidekke's Swedish subsidiary, Arcona, has entered an agreement with Genesta for the Zinko...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 hours agoNeuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome PR Newswire MELBOURNE, Australia, May 27, 2024 Highlights: Statistically significant improvement ...
China creates largest-ever mainland chip fund with US$47.5 billion investment
South China Morning Post· 29 minutes agoThe third phase of the China Integrated Circuit Industry Investment Fund has 19 equity investors,...
Novartis’ atrasentan shows to reduce proteinuria in Phase III IgAN trial
Clinical Trials Arena via Yahoo Finance· 4 hours agoNovartis has unveiled interim results from the Phase III ALIGN clinical trial where atrasentan...
Apellis and Sobi report data from Phase II C3 glomerulopathy trial
Clinical Trials Arena via Yahoo Finance· 4 hours agoApellis Pharmaceuticals and Sobi have announced positive one-year data from the Phase II NOBLE trial...
AstraZeneca and Daiichi Sankyo’s ADC improves survival in NSCLC trial
Clinical Trials Arena via Yahoo Finance· 2 hours agoAstraZeneca and Daiichi Sankyo have reported high-level overall survival (OS) results from the Phase...